Stoke Therapeutics (STOK) Financials

$29.03

$-0.31 (-1.06%)

As on 11-Sep-2026 16:00EDT

Market cap

$1,924 Mln

Revenue (TTM)

$28 Mln

P/E Ratio

--

P/B Ratio

5.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	27.59	184.42	36.56	8.78	12.41	3.00
Cost of Revenue	4.23	--	4.44	4.73	3.54	2.23
Gross Profit	23.36	184.42	36.56	8.78	12.41	-2.23
Operating Expenses	246.74	205.01	137.93	123.55	116.76	86.07
Operating Profit (EBIT)	-223.38	-20.59	-101.37	-114.77	-104.36	-86.07
Other Income	--	--	--	--	0.17	0.14
Profit before Tax	-209.18	-6.89	-88.98	-104.70	-101.07	-85.81
Provision for Tax	-1.28	--	-88.98	4.56	-7.96	-1.09
Profit after Tax (Net Income)	-207.90	-6.89	-88.98	-104.70	-93.11	-84.71
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-101.07	-85.81

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	345.55	352.46	229.02	159.57	184.85	217.78
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	6.49	8.10	2.48	37.96	39.82	3.95
Current Liabilities	41.93	57.88	40.06	30.82	31.39	17.14
Total Liabilities	435.90	418.43	271.56	228.34	256.07	238.87

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	71.43	112.73	38.80	13.00	12.00	9.65
Current Assets	322.54	305.70	232.76	215.34	244.07	229.22
Total Assets	435.90	418.43	271.56	228.34	256.07	238.87
Total Debt*	2.68	3.01	4.77	2.06	2.36	5.04
Net Current Assets	280.61	247.83	192.70	184.52	212.68	212.08

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	45.59	-86.85	-81.07	-31.87	-66.91
Cash Flow from Investing Activities	--	-186.81	-107.48	105.95	-45.88	-76.43
Cash from Financing Activities	--	97.39	131.09	53.01	46.41	1.28
Net Cash Inflow / Outflow	--	--	--	--	-31.34	-142.05

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-3.37	-0.12	-1.56	-2.33	-2.36	-2.30
Cash EPS ($)	--	-0.09	-1.52	-2.27	-2.32	-2.27
Adjusted Book Value ($)	--	6.04	4.02	3.55	4.69	5.91
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	0.78	-1.52	-1.80	-0.81	-1.82
Free Cash Flow per Share ($)	--	0.77	-1.53	-1.84	-0.91	-1.85

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-2.34	-45.01	-60.03	-45.42	-33.22
ROE (%)	-59.57	-2.37	-45.80	-60.80	-46.25	-33.63
ROA (%)	-48.40	-2.00	-35.60	-43.23	-37.63	-31.56
EBIT Margin (%)	-759.71	-3.73	-243.42	-1,192.47	-841.24	-2,868.83
Net Margin (%)	-753.60	-3.73	-243.42	-1,192.47	-740.61	-2,697.80
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-86.20	4.05	3.16	-0.29	3.14	--
EBIT Growth (%)	-489.84	92.26	15.01	-0.33	-21.25	-62.25
Net Profit Growth (%)	-496.12	92.26	15.01	-12.45	-9.91	-67.38
EPS Growth (%)	-499.12	0.92	0.33	0.01	-0.03	-0.59
Book Value Growth (%)	-8.81	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-269.17	-7.07	-2.26	-3.91	-10.43
Price / Book Value	5.77	5.26	2.75	1.48	1.97	4.06
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	52.48	-307.25	-4.80	-0.36	-1.33	-7.86
Close Price ($)	32.72	31.74	11.03	5.26	9.23	23.99
High Price ($)	40.22	38.69	17.58	14.00	26.60	71.58
Low Price ($)	11.19	5.35	4.09	3.35	6.88	17.76
Market Cap ($ Cr)	1,923.53	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.01	0.02	0.01	0.01	0.02
Short term debt to equity ratio	0.01	0.01	0.01	0.01	0.01	0.01
Current Ratio	7.69	5.28	5.81	6.99	7.77	13.37
Quick Ratio	7.69	--	--	--	7.43	17.75
Interest Coverage	-4,546.39	-765.00	-7.04	-10.57	-33.43	-717.21

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	31.60	4.29	1.91	0.73	4.74	4.40
Asset Turnover	0.06	0.53	0.15	0.04	0.05	0.01
Receivable days	--	8.52	3.82	13.56	10.60	8.40
Inventory Days	--	--	--	844.35	-3,305.49	-12,270.27
Payable days	--	--	172.39	95.04	162.79	317.75
Cash Conversion Cycle	--	--	--	762.87	-3,457.67	-12,579.62

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.